Skip to main content
Ocumension Therapeutics logo

Ocumension Therapeutics — Investor Relations & Filings

Ticker · 1477 ISIN · KYG674111011 LEI · 5493000USURI3SIL4Z85 HKEX Manufacturing
Open in API
Filings indexed 459 across all filing types
Latest filing 2024-08-28 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1477

About Ocumension Therapeutics

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to the research, development, and commercialization of first-in-class or best-in-class therapeutics. The company focuses on providing comprehensive treatment solutions for Chinese patients suffering from ocular diseases. Ocumension has established a complete ophthalmic drug product line, currently holding 20 drug assets covering both anterior and posterior segments of the eye. Its portfolio addresses major conditions such as chronic non-infectious uveitis, infective and allergic conjunctivitis, and diabetic macular edema. The company employs a strategy combining continuous scientific innovation, independent R&D, and strategic alliances to sustain the supply of innovative products across the ophthalmology field.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, treasury shares, and confirmations related to compliance with listing rules. The content is regulatory in nature, focused on disclosure of share transactions rather than financial performance or management commentary. It is not an annual or interim report, earnings release, or management discussion. It is a formal regulatory disclosure about share capital changes and repurchases. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the correct classification is POS with high confidence.
2024-08-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations of compliance with listing rules and regulatory requirements. It is a regulatory disclosure about share repurchase activity rather than a financial report or earnings release. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication or a certification. Therefore, the correct classification is POS with high confidence.
2024-08-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document also includes confirmations regarding compliance with listing rules and legal requirements. This type of filing is a formal disclosure of share repurchase activity and changes in capital structure, not a full financial report or earnings release. It fits the category of a company announcement about share repurchases and capital changes rather than an annual or interim report or regulatory certification. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief announcement or a certification but a substantive disclosure of share repurchase transactions.
2024-08-26 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from The Stock Exchange of Hong Kong Limited (Main Board Rules and GEM Rules), indicating it is a regulatory disclosure related to share repurchases and treasury shares. The content includes detailed tables of share repurchase transactions, confirmation statements about compliance with listing rules, and notes explaining the regulatory context. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a formal regulatory filing disclosing share repurchase activity and compliance confirmations. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement of a report publication.
2024-08-23 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return related to changes in issued shares and treasury shares, including share repurchases and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure about share capital changes and repurchases, not a full financial report or earnings release. It fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and content confirm it is a detailed disclosure rather than a brief announcement or a certification letter, so it is not RNS or RPA. Therefore, the correct classification is POS with high confidence.
2024-08-22 English
VOLUNTARY ANNOUNCEMENT PROPOSED ON-MARKET SHARE REPURCHASE
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by Ocumension Therapeutics regarding a proposed on-market share repurchase program. It details the board's intention to repurchase shares under an existing mandate, the funding source, regulatory compliance, and the strategic rationale behind the repurchase. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is an announcement of a capital action (share repurchase) rather than a report or detailed financial disclosure. Therefore, it fits the category of Transaction in Own Shares (POS). The document length (7282 characters) and content confirm it is a full announcement, not a brief notice or a report publication announcement.
2024-08-22 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.